Skip to content

Dossier

Red marks, brown marks: what actually fades them

A brown mark and a red mark left by the same pimple are not the same problem. One is pigment, the other is blood vessels, and the serum that helps one may do nothing for the other.

Revelika editors9 min read

The spot is gone; the mark is not. Skincare talk lumps everything an old breakout leaves behind into "acne scars", but most of what people mean are flat marks, not scars, and they come in two kinds. Telling them apart is not pedantry. It decides whether months of a brightening serum are aimed at the right target.

Dermatologists call the brown ones post-inflammatory hyperpigmentation (PIH) and the pink-to-red ones post-inflammatory erythema (PIE). The second term is young enough that a 2013 paper set out to introduce it to the dermatology vocabulary 2. This piece covers why the two differ, what has actually been tested against each, and where the evidence runs out.

Two marks, two mechanisms

PIH is excess pigment. Inflammation switches melanocytes up: they make more melanin and hand more of it to the surrounding skin cells. When the inflammation runs deep enough to damage the basal layer, melanin drops into the dermis, where macrophages swallow it 1. That explains the colour range, from tan to near-black, with a blue-grey cast when the pigment sits deep.

PIE is not pigment at all. It is dilated capillaries and small telangiectasias left behind once a lesion settles 4, possibly driven by inflammatory cytokines and new vessel growth 5. Melanin plays no part, so ingredients that work by blocking melanin have no reason to fade PIE, and no data show that they do.

Which one you get depends largely on skin tone. A working group of pigmentation experts puts it plainly: PIH is more common in darker skin and PIE in lighter skin, though either can appear in anyone 3. The authors who coined PIE noted that in skin types I to III, the discoloration after acne is often not hyperpigmentation at all 2.

PIH and PIE side by side
Brown marks (PIH)Red marks (PIE)
What it isExcess melanin in the epidermis or dermis 1Dilated vessels and telangiectasias 4
ColourTan to dark brown; blue-grey when deep 1Pink, red or purple
More common inDarker skin, types III–VI 3Lighter skin, types I–III 2,3
Under pressureStaysBlanches
Where the trials areTopicals and prescription retinoids 6,7,8Vascular lasers and IPL 4,14

Why brown marks hang around

Left alone, epidermal PIH takes months to years to fade. Dermal PIH, the blue-grey kind, may fade very slowly or not at all 1. It is also common: in a survey of acne patients cited by Davis and Callender, PIH affected 65.3% of African American, 52.7% of Hispanic and 47.4% of Asian patients 1. Many find the marks more distressing than the acne itself 3.

Two practical points follow from the mechanism. First, every new breakout is a new mark. That is why a 2023 expert consensus on acne-related hyperpigmentation put early, effective acne treatment, a topical retinoid plus benzoyl peroxide, ahead of any brightener 6. Second, irritation is inflammation too. Harsh acids, aggressive peels and stinging routines can deepen PIH in darker skin rather than clear it 1.

What fades brown marks

Start with the honest part. There are no large randomised trials for acne-related PIH, and the 2023 consensus says outright that evidence-based recommendations cannot be made for that reason; its authors relied on expert agreement instead 6. Nothing on the list below earns a "strong" grade. But the gap between "one decent trial" and "a plausible mechanism" is still wide.

Prescription retinoids. The best single study is from 1993, in the New England Journal of Medicine: 54 Black participants, 40 weeks, tretinoin 0.1% cream against vehicle. Treated facial marks lightened by 40% on colorimetry versus 18% with vehicle, with improvement visible from week four. The cost was retinoid dermatitis in half the treated group 7. Tretinoin, adapalene and tazarotene are medicines, and choosing between them is a dermatologist's call. Cosmetic retinol and retinal are gentler relatives with no PIH trials of their own, and are not used in pregnancy.

Azelaic acid. In a multicentre, double-blind trial in skin types IV to VI, 20% cream reduced facial hyperpigmentation more than vehicle over 24 weeks, at the price of some early burning and stinging 8. A more recent randomised trial in acne-related PIH found 20% azelaic acid and 5% tranexamic acid solution performed about the same 9. Its other advantage is that it treats the acne too. Revelika's profile lists 15% as the effective level and 20% as the ceiling; many serums carry less, and the studies don't say how much less still works.

Tranexamic acid. It is the darling of melasma research, but the PIH evidence is thinner. The main study is that comparison with azelaic acid: 30 people per arm, 12 weeks, similar results and fewer side effects with tranexamic acid in the first month 9. There was no placebo arm. The rest is small, often combination studies 5. Melasma results, including those for tablets, do not transfer to PIH automatically. Revelika's tranexamic acid profile puts the effective level at 3% and the ceiling at 5%.

Niacinamide. The mechanism is tidy: it does not slow melanin production but blocks its transfer into skin cells. In Japanese women, 5% niacinamide reduced hyperpigmentation more than vehicle in four weeks, but the paired trial had 18 participants and covered pigmentation in general, not acne marks 10. In melasma, 4% niacinamide came close to 4% hydroquinone in a small trial 11. It has not been studied for PIH in darker skin 1.

Everything else. Vitamin C has mostly been studied in melasma; arbutin, kojic acid and licorice root have little or no PIH-specific data, and kojic acid has a record of contact dermatitis 1. Superficial glycolic acid peels are generally tolerated in darker skin, but in a 16-patient trial adding them to a topical regimen made no significant difference 1. Hydroquinone remains the clinical mainstay for PIH, but it is a drug with its own risks, from irritation to ochronosis with long use, and whether to use it is for a doctor to decide 1,6.

What fades brown marks

, , ,

Tap an underlined ingredient to see what it does.

Actives with at least some PIH data, and the filter they depend on.
Post-acne marks: evidence for PIH, and what is known for PIE
  • Prescription retinoids (tretinoin and others)

    Moderate evidence

    PIH: 40-week RCT, 40% vs 18% lightening; dermatitis in half. PIE: no data. Prescribed by a doctor.6,7

  • Azelaic acid

    Moderate evidence

    PIH: vehicle-controlled RCT in skin types IV–VI, plus a head-to-head with tranexamic acid. Treats acne too. PIE: no data.8,9

  • UV and visible light drive pigmentation; the tinted-sunscreen RCT was in melasma. Not studied for PIE.1,12,13

  • Topical tranexamic acid

    Limited evidence

    PIH: one RCT, no placebo arm. PIE: case reports and a small trial of a 10% serum.5,9

  • Niacinamide

    Limited evidence

    Small trials in general hyperpigmentation and melasma, not PIH. PIE: no data.10,11

  • Glycolic acid peels

    Limited evidence

    Tolerated, but added nothing significant in a small trial. Irritation risk.1

  • Retinol, retinal

    Not enough evidence

    PIH data exist only for prescription retinoids; the transfer is unproven.7

  • Data mostly in melasma, or absent.1

And the red ones?

The good news: both PIH and PIE tend to resolve over time, unlike true scars 2. The less good news: if you don't want to wait, the evidence for red marks is thinner still. A 2022 systematic review found 18 eligible studies and no gold-standard treatment; most tested lasers and light devices, the pulsed dye laser above all 4. A 2026 review restricted to randomised trials found nine, with 301 participants, and could not name a preferred treatment: samples were small, follow-up short, and four trials carried a high risk of bias 14.

Among topicals, reviews call tranexamic acid, brimonidine and oxymetazoline promising 4; the last two are prescription drugs used for rosacea. For tranexamic acid in PIE, there are case reports with a 5% product and a small split-face randomised trial in which a 10% serum reduced redness in people with active acne 5. That 10% is double the ceiling in Revelika's profile. Lasers, IPL and tranexamic acid injections are procedures for a dermatologist to choose.

What not to expect: that pigment brighteners such as arbutin, kojic acid or vitamin C will take the redness out. They target melanin; PIE is vessels. The most useful thing a routine can do for red marks is not add inflammation: treat the acne and leave the skin alone.

For skin with red marks

, ,

Tap an underlined ingredient to see what it does.

Tranexamic acid is the only one here with PIE data, and it is limited. Panthenol and centella are there for comfort, not fading.

What a sensible routine looks like

The job is to calm the acne, keep light off the marks, and give one or two actives enough time. The studies above ran from 12 to 40 weeks, so judging anything before three months is premature.

  1. Morning: a gentle cleanse, then niacinamide (5% is the effective level in Revelika's profile) or azelaic acid.
  2. Morning, non-negotiable: broad-spectrum sunscreen. For brown marks on deeper skin tones, pick a tinted mineral formula with zinc oxide or titanium dioxide plus iron oxides. Reapply on long days outdoors.
  3. Evening: one brightening active, either azelaic acid or tranexamic acid (3%). Add retinol or retinal on alternate nights if your skin tolerates it.
  4. If it stings: cut the frequency rather than pushing through, and add panthenol and a plain moisturiser. On darker skin, irritation is a route to new marks.
  5. If the marks are red: keep the sunscreen, the acne treatment and the gentle care; tranexamic acid is optional, with modest expectations.
  6. Pregnancy: Revelika's data flag retinol and retinal as unsuitable and azelaic acid and niacinamide as suitable. Check your routine with your doctor.

If marks are blue-grey, don't budge after six months of consistent care, or keep appearing faster than they fade, see a dermatologist. Prescription retinoids, hydroquinone, oral tranexamic acid and lasers are their decisions, not something to pick off a shelf.

References


  1. 1Davis EC, Callender VD. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol. 2010;3(7):20–31. pmc.ncbi.nlm.nih.gov/articles/PMC2921758/
  2. 2Bae-Harboe YS, Graber EM. Easy as PIE (postinflammatory erythema). J Clin Aesthet Dermatol. 2013;6(9):46–47. pmc.ncbi.nlm.nih.gov/articles/PMC3780804/
  3. 3Elbuluk N, Grimes P, Chien A, et al. The pathogenesis and management of acne-induced post-inflammatory hyperpigmentation. Am J Clin Dermatol. 2021;22(6):829–836. doi.org/10.1007/s40257-021-00633-4
  4. 4Kalantari Y, Dadkhahfar S, Etesami I. Post-acne erythema treatment: a systematic review of the literature. J Cosmet Dermatol. 2022;21(4):1379–1392. doi.org/10.1111/jocd.14804
  5. 5Chen T, Xue J, Wang Q. Tranexamic acid for the treatment of hyperpigmentation and telangiectatic disorders other than melasma: an update. Clin Cosmet Investig Dermatol. 2024;17:2151–2163. pmc.ncbi.nlm.nih.gov/articles/PMC11439988/
  6. 6Taylor S, Elbuluk N, Grimes P, et al. Treatment recommendations for acne-associated hyperpigmentation: results of the Delphi consensus process and a literature review. J Am Acad Dermatol. 2023;89(2):316–323. doi.org/10.1016/j.jaad.2023.02.053
  7. 7Bulengo-Ransby SM, Griffiths CE, Kimbrough-Green CK, et al. Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients. N Engl J Med. 1993;328(20):1438–1443. doi.org/10.1056/NEJM199305203282002
  8. 8Lowe NJ, Rizk D, Grimes P, Billips M, Pincus S. Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients. Clin Ther. 1998;20(5):945–959. doi.org/10.1016/s0149-2918(98)80076-3
  9. 9Sobhan M, Talebi-Ghane E, Poostiyan E. A comparative study of 20% azelaic acid cream versus 5% tranexamic acid solution for the treatment of postinflammatory hyperpigmentation in patients with acne vulgaris: a single-blinded randomized clinical trial. J Res Med Sci. 2023;28:18. pmc.ncbi.nlm.nih.gov/articles/PMC10199364/
  10. 10Hakozaki T, Minwalla L, Zhuang J, et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol. 2002;147(1):20–31. doi.org/10.1046/j.1365-2133.2002.04834.x
  11. 11Navarrete-Solís J, Castanedo-Cázares JP, Torres-Álvarez B, et al. A double-blind, randomized clinical trial of niacinamide 4% versus hydroquinone 4% in the treatment of melasma. Dermatol Res Pract. 2011;2011:379173. pmc.ncbi.nlm.nih.gov/articles/PMC3142702/
  12. 12Mahmoud BH, Ruvolo E, Hexsel CL, et al. Impact of long-wavelength UVA and visible light on melanocompetent skin. J Invest Dermatol. 2010;130(8):2092–2097. doi.org/10.1038/jid.2010.95
  13. 13Castanedo-Cazares JP, Hernandez-Blanco D, Carlos-Ortega B, Fuentes-Ahumada C, Torres-Álvarez B. Near-visible light and UV photoprotection in the treatment of melasma: a double-blind randomized trial. Photodermatol Photoimmunol Photomed. 2014;30(1):35–42. doi.org/10.1111/phpp.12086
  14. 14Alhussain A, Majrashi M, Omar AlMubarak K, et al. Post-acne erythema: a systematic review of randomized controlled trials on the comparative efficacy and safety of interventions across clinical, instrumental, and patient-reported outcomes. Cureus. 2026;18(9):e116495. pmc.ncbi.nlm.nih.gov/articles/PMC13677114/

More from this issue


Ingredients: published research, conservative grading, uncertainty stated plainly, no paid placements, partner links disclosed where they appear.

Revelika

A science-forward beauty ingredient encyclopedia. Every entry is written from published research and graded conservatively before it publishes.


Content is educational, not medical advice. When evidence is uncertain we say so — and we default to caution on pregnancy safety.

We use Google Analytics and Yandex Metrica (including Webvisor session recording) to understand how the site is used. In the EEA and UK these load only after you accept analytics cookies, and you can withdraw consent at any time by declining.

© 2026 Revelika · built by ThirteenTabsEvidence-based · written from published research, graded conservatively